- Home
- IDYA vs ALRM Comparison
IDYA vs ALRM Comparison
Compare IDYA & ALRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDYA
- ALRM
- Stock Information
- Founded
- IDYA 2015
- ALRM 2000
- Country
- IDYA United States
- ALRM United States
- Employees
- IDYA N/A
- ALRM N/A
- Industry
- IDYA Biotechnology: Pharmaceutical Preparations
- ALRM Computer Software: Prepackaged Software
- Sector
- IDYA Health Care
- ALRM Technology
- Exchange
- IDYA Nasdaq
- ALRM Nasdaq
- Market Cap
- IDYA 2.6B
- ALRM 2.7B
- IPO Year
- IDYA 2019
- ALRM 2015
- Fundamental
- Price
- IDYA $26.91
- ALRM $66.29
- Analyst Decision
- IDYA Strong Buy
- ALRM Buy
- Analyst Count
- IDYA 12
- ALRM 6
- Target Price
- IDYA $53.67
- ALRM $65.33
- AVG Volume (30 Days)
- IDYA 997.6K
- ALRM 400.5K
- Earning Date
- IDYA 11-04-2024
- ALRM 11-07-2024
- Dividend Yield
- IDYA N/A
- ALRM N/A
- EPS Growth
- IDYA N/A
- ALRM 80.16
- EPS
- IDYA N/A
- ALRM 2.31
- Revenue
- IDYA $3,922,000.00
- ALRM $923,824,000.00
- Revenue This Year
- IDYA N/A
- ALRM $8.17
- Revenue Next Year
- IDYA $251.89
- ALRM $4.58
- P/E Ratio
- IDYA N/A
- ALRM $29.14
- Revenue Growth
- IDYA N/A
- ALRM 6.98
- 52 Week Low
- IDYA $24.72
- ALRM $51.87
- 52 Week High
- IDYA $47.74
- ALRM $77.29
- Technical
- Relative Strength Index (RSI)
- IDYA 45.25
- ALRM 69.31
- Support Level
- IDYA $24.72
- ALRM $66.70
- Resistance Level
- IDYA $26.86
- ALRM $68.00
- Average True Range (ATR)
- IDYA 1.23
- ALRM 1.40
- MACD
- IDYA 0.04
- ALRM -0.20
- Stochastic Oscillator
- IDYA 46.89
- ALRM 71.49
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It is engaged in applying capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality. The company's product candidate IDE196 is a protein kinase C, or PKC, an inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations.
About ALRM Alarm.com Holdings Inc.
Alarm.com Holdings Inc has two reportable segments: Alarm.com & Other. The Alarm.com segment represents the cloud-based Software platforms for intelligently connected property & related solutions. The other segment is focused on researching, developing & offering residential & commercial automation solutions & energy management products & services in adjacent markets. The majority of revenue is from the Alarm.com segment. The platform allows home & business owners to secure their properties and automate & control an array of connected devices. SaaS & license fees from service providers, who resell these services & pay Alarm.com a monthly subscription, are the sources of revenue for the firm. The majority of revenue is generated in the United States & Canada.